Karen Clark

Founded in 1989, Riverside Partners invests in leading healthcare and technology companies based in North America, with a particular focus on companies that are founder- and family-owned. Riverside targets proven, profitable companies with revenues between $20 million and $200 million. The companies in which Riverside has invested typically generate sales between $10 million and $100 million, and EBITDA between $5 million and $25 million. The firm focuses on companies with headquarters in North America. The firm is currently investing Riverside Fund V, L.P., a $561 million equity fund, with committed capital from leading institutional investors, including endowments and foundations, family offices, pension funds, and fund of funds.